<DOC>
	<DOCNO>NCT02872298</DOCNO>
	<brief_summary>Prospective , multicenter , single-arm ( non-randomized ) study Targeted Lung Denervation ( TLD ) Therapy subject severe , refractory asthma .</brief_summary>
	<brief_title>Evaluating Safety Feasibility TLD Treatment Moderate Severe Refractory Asthma</brief_title>
	<detailed_description>Prospective , multicenter , single-arm ( non-randomized ) study . All patient undergo run period optimal medical therapy part eligibility test . After additional baseline screen prior procedure patient take course steroid prior procedure . Final determination initiate treatment make initial airway inspection . A total 30 patient treat . Inflammatory biomarkers ( wash brushing ) collect patient bronchoscopic specimen collect last 15 patient . Matching sample collect required bronchoscopic follow . All patient prescribe steroid antibiotic post procedure . All patient provide mobile handheld spirometer measure record daily peak expiratory flow Forced Expiratory Volume 1 second ( FEV1 ) value treatment monitor lung function . Patient follow-up conduct 3 year .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Glucocorticoids</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Patient provide write informed consent Diagnosis asthma take regular maintenance medication specify study protocol Prebronchodilator FEV1 ≥60 % predict 4 week medication runin glucocorticoid ( ≥800 budesonide equivalent ) + Long Acting BetaAgonist ( LABA ) therapy Subject least two day asthma symptom 4weeks Baseline Diary Period Stable asthma past 6 week define study protocol Women child bear potential must negative pregnancy test agree become pregnant duration study Nonsmoker least 1 year Patient candidate bronchoscopy opinion physician per hospital guideline Patient candidate undergo methacholine challenge test Patient willing , able agrees complete protocol require baseline follow test comply medication requirement ≥ 3 low respiratory tract infection require antibiotic previous 12 month respiratory tract infection within previous 6 week Subject 3 hospitalization asthma exacerbation past year OR history lifethreatening asthma , define study protocol Exacerbation ≤ 6 week prior enrollment Steroid burst ≤ 6 week enrollment use oral steroid time enrollment Known sensitivity contraindication bronchoprovocation test per standard guideline History poor medication compliance Prior lung chest procedure Other chronic pulmonary disorder associate asthmalike symptom , include ( limited ) cystic fibrosis , chronic obstructive pulmonary disease , chronic bronchitis , vocal chord dysfunction sole cause asthma symptom , severe scoliosis chest wall deformity affect lung function , congenital disorder lung airway Preexisting diagnosis pulmonary hypertension define study protocol Uncontrolled diabetes evidence HbA1c &gt; 7 % Treated immunosuppressant therapy within last 2 year Patient implantable electronic device Known hypersensitivity anticholinergic drug component Known allergy medication require bronchoscopy general anesthesia Patient unable stop blood thin medication 7 day prior 7 day procedure Documented history untreated severe obstructive sleep apnea Patient disease condition might interfere completion procedure study Screening chest CT scan reveals bronchi anatomy fully treat available catheter size discovery pulmonary nodule require followup intervention unless proven benign Patients abdominal surgical procedure stomach , esophagus pancreas Patients Gastroparesis Cardinal Symptom Index ( GCSI ) score ≥ 18 prior treatment Recent ( &lt; 3 month ago ) narcotic use Patient currently enrol another clinical trial complete followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Severe</keyword>
	<keyword>Refractory</keyword>
</DOC>